Protein and Peptide Substances in the Treatment of Respiratory Syncytial Infection: Current State

Protein and Peptide Substances in the Treatment of Respiratory Syncytial Infection: Current State

Respiratory syncytial virus infection (RSVI) is an acute medical and social problem in many countries globally. Infection is most dangerous for infants under one year old and the elderly. Despite its epidemiological relevance, only two drugs are registered for clinical use against RSVI: ribavirin (a...

Full description

Bibliographic Details
Main Authors: Anna A. Shtro, Galina D. Petukhova, Aleksandra S. Romanova
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Molecules
Subjects:
respiratory syncytial virus
antivirals
viral diseases
respiratory diseases
childhood infections
Online Access:https://www.mdpi.com/1420-3049/27/7/2263

Similar Items

Similar Items